NASDAQ:TLSI | Cash Flow Statement | TriSalus Life Sciences, Inc.

Complete source-backed cash-flow history.

Available history
2021-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$9.19M
2026-03-31$1.54M-$6.48M$141,000.00-$141,000.00$42.39M
2025-12-31-$9.75M-$2.48M$41,000.00-$41,000.00$277,000.00
2025-09-30-$10.81M
2025-06-30-$8.29M
2025-03-31-$10.38M-$4.5M$754,000.00-$714,000.00$9.69M
2024-12-31-$10.11M-$5.71M$50,000.00-$50,000.00$2.99M
2024-09-30-$2.4M
2024-06-30-$4.33M
2024-03-31-$13.21M-$10.87M$66,000.00-$66,000.00$3.13M
2023-12-31-$35.64M-$9.18M$372,000.00-$372,000.00$43,000.00
2023-09-30-$1.43M
2023-06-30-$13.99M
2023-03-31-$8.31M-$10.5M$7,000.00-$74,000.00$7.93M
2022-12-31-$22.54M-$8.31M$204,000.00-$272,000.00$5.91M
2022-09-30-$8.09M
2022-06-30-$8.68M
2022-03-31-$7.87M-$425,954.00$11,000.00$265,000.00
2021-12-31$2.9M-$680,921.00
2021-09-30$1.86M
2021-06-30$378,866.00
2021-03-31-$372,034.00-$205,848.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$39.23M-$18.01M$918,000.00-$838,000.00$30.76M
2024-12-31-$30.05M-$40.84M$345,000.00-$345,000.00$37.94M
2023-12-31-$59.36M-$50.58M$588,000.00-$1.59M$54.63M
2022-12-31-$47.19M-$32.31M$655,000.00-$1.79M$232.37M$13.46M
2021-12-31$4.77M-$1.74M$60,000.00$544,000.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.